Targeting T2 Inflammation (EU)

This fascinating exploration of key cytokines, immune cells, and associated pathways includes the latest in biologic therapies that target Type 2 inflammation, which plays a significant role in the pathophysiology of several chronic conditions. In real time, get ready to dive into targeted therapies at the molecular level and their impact on symptom amelioration and improvements in quality of life (QoL).